Showing 1501-1510 of 6950 results for "".
Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TConnective Tissue Disorders Update 2025: Dr. Vleugels
https://practicaldermatology.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.Addressing Skin Changes During Menopause: An Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/addressing-skin-changes-during-menopause-an-update/20220/New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.Acne and Rosacea: Dr. Baldwin
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/acne-and-rosacea-dr-baldwin/32693/Hilary Baldwin, MD, talks about a topic that she did not have time to cover during "Update 2025: Acne and Rosacea" at Maui Derm 2025—emergency contraception in patients on isotretinoin.Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.Noah Worcester 2024: Dr. Adams on Sports Dermatology
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-adams-sports-dermatology/24584/Brian Adams, MD, MPH, summarizes his lecture on treating professional athletes at the 2024 Noah Worcester Dermatological Society meeting.Articles, Approvals, and Updates of 2023
https://practicaldermatology.com/topics/skin-cancer-photoprotection/articles-approvals-and-updates-of-2023/20231/Daniel Schlessinger, MD, provides his review of some of the year's most important articles, approvals, and updates, and describes how they relate to skin cancers, the first topical gene therapy, hidradenitis suppurativa treatment, and iPledge updates.DermWireTV: Novan EPI Acquisition, Champions for Change Gala, Mt. Sinai Alopecia Center
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-novan-epi-acquisition-champions-for-change-gala-mt-sinai-alopecia-center/20070/EPI Health is now a Novan company; the combined company will employ approximately 100 staff. Novan’s lead candidate, berdazimer gel 10.3%, performed well in a phase 3 study for the treatment of molluscum contagiosum. The Skin Cancer Foundation is gearing up for its signature fundraising event: The CWe've Got to Do Better
https://practicaldermatology.com/topics/practice-management/weve-got-to-do-better/20018/As a specialty, dermatology is doing more to address issues of diversity, equity, and inclusion, but Jeanine Downie, MD says there is more to do. She discusses issues such as dealing with microaggressions, increasing diversity in the workforce, and seeing the humanity in every patient.Scientifically Speaking: Advances in Microneedling
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-advances-in-microneedling/20012/Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD discuss PRP, RF micondeeling, and other advances in patient care with host Joel L. Cohen, MD.